Adarza Biosystems Inc. Gets New Life Science Seed Fund's First $250K Investment
7/18/2013 8:23:01 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A chip-based biomarker discovery platform that allows scientists to quickly and simultaneously explore the regulation of several protein targets has garnered $250,000 from a new life science fund. Adarza BioSystems Inc. develops and manufactures a new multiplex immunoassay technology that can quickly identify and measure proteins in blood and other clinical and point-of-care samples, like a drop of blood. The technology is highly sensitive and allows researchers to run hundreds of tests on a single chip, the company says on its website.
Help employers find you! Check out all the jobs and post your resume.
comments powered by